Survey of Ophthalmology
Volume 54, Issue 6 , Pages 663-670 , November 2009

Plus Disease

  • Bradley V. Davitt, MD

      Affiliations

    • Departments of Ophthalmology and Pediatrics, Cardinal Glennon Children's Medical Center, Saint Louis University School of Medicine, St. Louis, Missouri, USA
    • Corresponding Author InformationReprint address: Bradley V. Davitt, MD, Cardinal Glennon Children's Medical Center, 1465 South Grand Boulevard, St. Louis, MO 63104.
    • ,
  • David K. Wallace, MD, MPH

      Affiliations

    • Departments of Ophthalmology and Pediatrics, Duke University School of Medicine, Durham, North Carolina, USA

References 

  1. Ahmad S, Wallace DK, Freedman SF, Zhao Z. Computer-assisted assessment of plus disease in retinopathy of prematurity using video indirect ophthalmoscopy images. Retina. 2008;28:1458–1462
  2. Aylward SR, Bullitt E. Initialization, noise, singularities, and scale in height ridge traversal for tubular object centerline extraction. IEEE Trans Med Imaging. 2002;21:61–75
  3. Baum JD. Retinal artery tortuosity in ex-premature infants: 18-year follow-up on eyes of premature infants. Arch Dis Child. 1971;46:247–252
  4. Capowski JJ, Kylstra JA, Freedman SF. A numerical index based on spatial frequency for the tortuosity of retinal vessels and its application to plus disease in retinopathy of prematurity. Retina. 1995;15(6):490–500
  5. Chiang MF, Jiang L, Gelman R, et al. Interexpert agreement of plus disease diagnosis in retinopathy of prematurity. Arch Ophthalmol. 2007;125(7):875–880
  6. Coats DK. Retinopathy of prematurity: involution, factors predisposing to retinal detachment, and expected utility of preemptive surgical reintervention. Trans Am Ophthalmol Soc. 2005;103:281–312
  7. Cryotherapy for Retinopathy of Prematurity Cooperative Group. The natural ocular outcome of premature birth and retinopathy. Status at 1 year. Arch Ophthalmol. 1994;112(7):903–912
  8. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity: preliminary results. Arch Ophthalmol. 1988;106(4):471–479
  9. Early Treatment For Retinopathy Of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol. 2003;121(12):1684–1694
  10. Fielder AR. Preliminary results of treatment of eyes with high-risk prethreshold retinopathy of prematurity in the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol. 2003;121(12):1769–1770
  11. Fielder AR, Shaw DE, Robinson J, Ng YK. Natural history of retinopathy of prematurity: a prospective study. Eye. 1992;6(Pt 3):233–242
  12. Fielder AR, Wilkinson AR. The further refinement of ROP treatment. commentary on the early treatment of retinopathy of prematurity study: structural findings at 2 years of age. Br J Ophthalmol. 2007;91(2):136–137
  13. Flynn JT, O'Grady GE, Herrera J, et al. Retrolental fibro-plasia: I. Clinical observations. Arch Ophthalmol. 1977;95(2):217–223
  14. Freedman SF, Kylstra JA, Capowski JJ, et al. Observer sensitivity to retinal vessel diameter and tortuosity in retinopathy of prematurity: a model system. J Pediatr Ophthalmol Strabismus. 1996;33(4):248–254
  15. Freedman SF, Kylstra JA, Hall JG, Capowski JJ. Plus disease in retinopathy of prematurity-photographic evaluation by an expert panel (abstract). Invest Ophthalmol Vis Sci. 1995;36:76
  16. Gelman R, Jiang L, Du YE, et al. Plus disease in retinopathy of prematurity: pilot study of computer-based and expert diagnosis. J AAPOS. 2007;11(6):532–540
  17. Gelman R, Martinez-Perez ME, Vanderveen DK, et al. Diagnosis of plus disease in retinopathy of prematurity using Retinal Image multiScale Analysis. Invest Ophthalmol Vis Sci. 2005;46(12):4734–4738
  18. Hartnett ME, McColm JR. Retinal features predictive of progressive stage 4 retinopathy of prematurity. Retina. 2004;24(2):237–241
  19. Hartnett ME, Martiniuk D, Byfield G, et al. Neutralizing VEGF decreases tortuosity and alters endothelial cell division orientation in arterioles and veins in a rat model of ROP: relevance to plus disease. Invest Ophthalmol Vis Sci. 2008;49(7):3107–3114
  20. Heneghan C, Flynn J, O'Keefe M, Cahill M. Characterization of changes in blood vessel width and tortuosity in retinopathy of prematurity using image analysis. Medical Image Analysis. 2002;6(4):407–429
  21. Hix IE. A review of retrolental fibroplasia, with an analysis of the fundoscopic appearance as an aid to prognosis. M.S. Thesis, University of Colorado, 1953
  22. Ho M, Hsu HT, Rich KA, et al. Differences in retinal angiogenic response to sustained intravitreal release of VEGF and bFGF between different breeds of rabbits. IOVS. 2000;41(4):518
  23. Holland DR, Saunders RA, Kagemann LE, et al. Color doppler imaging of the central retinal artery in premature infants undergoing examination for retinopathy of prematurity. J AAPOS. 1999;3(4):194–198
  24. Hughes S, Gardiner T, Baxter L, Chan-Ling T. Changes in pericytes and smooth muscle cells in the kitten model of retinopathy of prematurity: implications for plus disease. Inv Ophthalmol Vis Sci. 2007;48:1368–1379
  25. International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol. 2005;123(7):991–999
  26. Johnston SC, Wallace DK, Freedman SF, et al. Tortuosity of Arterioles and Venules in Quantifying Plus Disease. J AAPOS. 2009;2:181–185
  27. Keegan SJ, Mills MD, Karp KA, Grunwald JE. Semiautomated analysis of retinal vessel diameter in retinopathy of prematurity patients with and without plus disease. AJO. 2007;143(4):723–725
  28. Kingham JD. Acute retrolental fibroplasia. Arch Ophth. 1977;95:39–47
  29. Koreen S, Gelman R, Martinez-Perez ME, et al. Evaluation of a computer-based system for plus disease diagnosis in retinopathy of prematurity. Ophthalmology. 2007;114(12):e59–e67
  30. Owens WC, Owens EU. Retrolental fibroplasia in premature infants. Am J Ophthalmol. 1949;32:1–21
  31. Palmer EA, Flynn JT, Hardy RJ, et al. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Incidence and early course of retinopathy of prematurity. Ophthalmology. 1991;98(11):1628–1640
  32. Patton N, Aslam TM, MacGillivray T, et al. Retinal image analysis: concepts, applications and potential. Prog Retin Eye Res. 2006;25:99–127
  33. Phelps DL. It's plus disease, isn't it?. Arch Ophthalmol. 2007;125(7):963–964
  34. Quinn GE. The dilemma of digital imaging in retinopathy of prematurity. J AAPOS. 2007;11(6):529–530
  35. Quinn GE, Schaffer DB, Johnson L. A revised classification of retinopathy of prematurity. Am J Ophthalmol. 1982;94(6):744–749
  36. Saunders RA, Bluestein EC, Berland JE, et al. Can non-ophthalmologists screen for retinopathy of prematurity?. J Pediatr Ophthalmol Strabismus. 1995;32(5):302–304
  37. Saunders RA, Bluestein EC, Sinatra RB, et al. The predictive value of posterior pole vessels in retinopathy of prematurity. J Pediatr Ophthalmol Strabismus. 1995;32(12):82–85
  38. Schaffer DB, Johnson L, Quinn GE, Boggs TR. A classification of retrolental fibroplasias to evaluate vitamin E therapy. Ophthalmology. 1979;86:1749–1760
  39. Schaffer DB, Palmer EA, Plotsky DF, et al. Prognostic factors in the natural course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology. 1993;100(2):230–237
  40. Swanson C, Cocker KD, Parker KH, et al. Semiautomated computer analysis of vessel growth in preterm infants without and with ROP. Br J Ophthalmol. 2003;87(12):1474–1477
  41. The Committee for the Classification of Retinopathy of Prematurity. An international classification of retinopathy of prematurity. Arch Ophthalmol. 1984;102(8):1130–1134
  42. The STOP-ROP Multicenter Study Group. Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes. Pediatrics. 2000;105(2):295–310
  43. Uemura Y. Current status of retrolental fibroplasia: report of the joint committee for the study of retrolental fibroplasia in Japan. Jpn J Ophthalmol. 1977;21:366–378
  44. Wallace DK, Freedman SF, Zhao Z. A Pilot study using ROPtool to measure retinal dilation. Retina. 2009 May 27. [Epub ahead of print]
  45. Wallace DK, Freedman SF, Zhao Z, Jung SH. Accuracy of ROPtool vs individual examiners in assessing retinal vascular tortuosity. Arch Ophthalmol. 2007;125(11):1523–1530
  46. Wallace DK, Jomier J, Aylward SR, Landers MB. Computer-automated quantification of plus disease in retinopathy of prematurity. J AAPOS. 2003;7(2):126–130
  47. Wallace DK, Kylstra JA, Chesnutt DA. Prognostic significance of vascular dilation and tortuosity insufficient for plus disease in retinopathy of prematurity. J AAPOS. 2000;4(4):224–229
  48. Wallace DK, Quinn GE, Freedman SF, Chiang MF. Agreement among pediatric ophthalmologists in diagnosing plus and pre-plus disease in retinopathy of prematurity. J AAPOS. 2008;12:352–356
  49. Wallace DK, Zhao Z, Freedman SF. A pilot study using “ROPTool” to quantify plus disease in retinopathy of prematurity. J AAPOS. 2007;11(4):381–387
  50. Wilson CM, Cocker KD, Moseley MJ, et al. Computerized analysis of retinal vessel width and tortuosity in premature infants. Invest Ophthalmol Vis Sci. 2008;49:3577–3585

 The authors reported no proprietary or commercial interest in any product mentioned or concept discussed in this article. Supported by an unrestricted grant from Research to Prevent Blindness, Inc., New York, New York, USA.

PII: S0039-6257(09)00066-6

doi: 10.1016/j.survophthal.2009.02.021

Survey of Ophthalmology
Volume 54, Issue 6 , Pages 663-670 , November 2009

Article Tools

* Image Usage & Resolution